NexImmune, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
NexImmune, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
  • NexImmune, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.18M, a 442% increase year-over-year.
  • NexImmune, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.01M, a 5.63% increase year-over-year.
  • NexImmune, Inc. annual Nonoperating Income (Expense) for 2023 was $629K, a 9.11% increase from 2022.
  • NexImmune, Inc. annual Nonoperating Income (Expense) for 2022 was $577K, a 75.5% decline from 2021.
  • NexImmune, Inc. annual Nonoperating Income (Expense) for 2021 was $2.35M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $629K +$52.5K +9.11% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $577K -$1.78M -75.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $2.35M +$4.37M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$2.01M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.